New FDA guidance signals a major shift for CAR-T development, calling for randomized trials with standard-of-care control groups and clear evidence of superiority over existing therapies, while ...
Randomized split face trial suggests intradermal botulinum toxin A for post acne erythema reduces redness and sebum versus broadband light with similar short term safety.
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback